Selected article for: "IFN response and immune system"

Author: Qian, Wei; Wei, Xiaoqin; Guo, Kelei; Li, Yongtao; Lin, Xian; Zou, Zhong; Zhou, Hongbo; Jin, Meilin
Title: The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-ß Production by Targeting TNF Receptor-Associated Factor 3
  • Document date: 2017_7_3
  • ID: 00mqmpzw_37
    Snippet: The MAVS-TRAF3 complex is a focal point of RLR-directed signaling response (42, 43) . TRAF3 localizes to the endoplasmic reticulum (ER) and needs to be recruited to mitochondrial MAVS in order to activate TBK1 complexes (44) . Many viral proteins, accessory and non-structural proteins in particular, hijack TRAF3 or the TRAF3 complex to mediate immune evasion. SARS coronavirus M protein or Open Reading Frame-9b prevents the formation of TRAF3-TANK.....
    Document: The MAVS-TRAF3 complex is a focal point of RLR-directed signaling response (42, 43) . TRAF3 localizes to the endoplasmic reticulum (ER) and needs to be recruited to mitochondrial MAVS in order to activate TBK1 complexes (44) . Many viral proteins, accessory and non-structural proteins in particular, hijack TRAF3 or the TRAF3 complex to mediate immune evasion. SARS coronavirus M protein or Open Reading Frame-9b prevents the formation of TRAF3-TANK-TBK1/IKKε complex or MAVS-TRAF3/TRAF6 signalosome to evade host innate immunity (45, 46) . SARS-CoV papain-like protease interacts with and disrupts STING-TRAF3-TBK1 complex, it also inhibits the TLR7-mediated innate immunity through removing Lys63linked ubiquitin chains of TRAF3 and TRAF6 (47, 48) . Herpes simplex virus 1 ubiquitin-specific protease UL36 deubiquitinates TRAF3 then counteracts the IFN-β pathway (49) . Over the past 10 years, there have been major advances in understanding how influenza A viruses successfully escape the surveillance of the immune system. The current report furthers this research revealing the surprising finding that NS1/126-225 acts by targeting TRAF3; specifically, NS1/126-225 targets the TRAF domain of TRAF3. TRAF3 links the upstream IFN signaling responses of MAVS to TBK1 relying on the TRAF domain. This report also shows that a specific interaction between TRAF3 and MAVS was observed when TRAF3 and MAVS were co-expressed in 293T cells. However, the interaction between TRAF3 and MAVS was disrupted in the presence of NS1/126-225. Interestingly, the interaction between MAVS and IKKε was markedly increased in NS1/126-225-expressing cells. It has been previously demonstrated that, after Sev infection, K63-linked polyubiquitination at Lys500 of MAVS recruits IKKε to the mitochondria, functionally causes release of TRAF3 from MAVS initiating the signal to shutdown the IFN response (31) . The MAVS-IKKε complex was enhanced when NS1/126-225 was present, indicating that NS1/126-225 can utilize this process to shut down further activation of IFN pathway. Taken together, these data indicate that NS1/126-225 impedes the interactions between components of MAVS-TRAF3 complex, preventing the phosphorylation of IRF3, where it would activate the IFN-β response.

    Search related documents:
    Co phrase search for related documents
    • immune system surveillance and viral protein: 1, 2
    • immunity innate and major advance: 1
    • immunity innate and mavs IKKε complex: 1
    • immunity innate and non structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • immunity innate and RLR direct: 1
    • immunity innate and Sev infection: 1, 2, 3, 4
    • immunity innate and signal initiate: 1
    • immunity innate and signal response: 1, 2, 3, 4
    • immunity innate and specific interaction: 1, 2, 3
    • immunity innate and STING complex: 1, 2, 3, 4
    • immunity innate and TBK1 complex: 1, 2, 3, 4, 5, 6
    • immunity innate and TBK1 IKKε: 1, 2, 3, 4, 5
    • immunity innate and TRAF domain: 1
    • immunity innate and ubiquitin specific protease: 1
    • immunity innate and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • major advance and viral protein: 1